Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 713 Projects
Project # Contact PI Funding Organization Fiscal Year
Blood-based biomarkers of Alzheimer's disease and neurodegeneration in the FINGER multidomain trial
GC-201906-2018916 Miia Kivipelto Alzheimer's Drug Discovery Foundation 2023
Use of an intrinsic brain activity biomarker for the earliest prediction of cognitive decline
GC-202202-2022659 Leslie Prichep Alzheimer's Drug Discovery Foundation 2023
Commercialization of RetiSpec's Novel Artificial Intelligence (AI) Software for the Detection of Early Signs of Alzheimer's disease Through Scalable Retinal Imaging
GDAPB-202211-2024346 Eliav Shaked Alzheimer's Drug Discovery Foundation 2023
Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's disease
ADDF-54 Sninsky, John Alzheimer's Drug Discovery Foundation 2022
Clinical Implementation of Blood-Based Biomarkers for Alzheimer’s Disease: Clinical Validation, IVD Product Development, and Market Development
ADDF-55 Wilson, David Alzheimer's Drug Discovery Foundation 2022
Identifying a Patient-Specified Core Digital Measures Set in Alzheimer’s Disease and Related Dementias
ADDF-56 Goldsack, Jennifer Alzheimer's Drug Discovery Foundation 2022
The development and evaluation of a clinical RT-QuIC test for diagnosis of TDP-43 linked Fronto-temporal dementias
GC-202101-2021209 Neil McKenzie Alzheimer's Drug Discovery Foundation 2022
Blood-Brain Barrier Imaging in Mild Cognitive Impairment and Alzheimer Disease
GC-202110-2022362 Jeremy Ford Alzheimer's Drug Discovery Foundation 2022
Validation of a Novel Magnetic Resonance Imaging (MRI) Technology for both Diagnostic Screening and Quantification of Brain Vascular Physiology in Alzheimer's-Disease-Related Dementias
GC-202207-2023781 Codi Gharagouzloo Alzheimer's Drug Discovery Foundation 2022
Validation of a novel, accessible, scalable, and affordable blood-based p-tau 217 assay for clinical use
GDAPB-202205-2023390 Andreas Jeromin Alzheimer's Drug Discovery Foundation 2022